Report Detail

Pharmaceuticals & Healthcare Hyperalgesia - Pipeline Review, H2 2019

  • RnM3727945
  • |
  • 05 September, 2019
  • |
  • Global
  • |
  • 37 Pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Hyperalgesia - Overview

              Hyperalgesia - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Hyperalgesia - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Hyperalgesia - Companies Involved in Therapeutics Development

                                      Cara Therapeutics Inc

                                        Charleston Laboratories Inc

                                          H. Lundbeck AS

                                            Novartis AG

                                              Hyperalgesia - Drug Profiles

                                                ABX-1431 - Drug Profile

                                                  Product Description

                                                    Mechanism Of Action

                                                      R&D Progress

                                                        AX-007 - Drug Profile

                                                          Product Description

                                                            Mechanism Of Action

                                                              R&D Progress

                                                                BAM-822 - Drug Profile

                                                                  Product Description

                                                                    Mechanism Of Action

                                                                      R&D Progress

                                                                        CR-701 - Drug Profile

                                                                          Product Description

                                                                            Mechanism Of Action

                                                                              R&D Progress

                                                                                Drug for Hyperalgesia - Drug Profile

                                                                                  Product Description

                                                                                    Mechanism Of Action

                                                                                      R&D Progress

                                                                                        ketoprofen - Drug Profile

                                                                                          Product Description

                                                                                            Mechanism Of Action

                                                                                              R&D Progress

                                                                                                mol-002291 - Drug Profile

                                                                                                  Product Description

                                                                                                    Mechanism Of Action

                                                                                                      R&D Progress

                                                                                                        Monoclonal Antibody to Inhibit TGF-Beta-1 for Chronic Pancreatitis Pain and Hyperalgesia - Drug Profile

                                                                                                          Product Description

                                                                                                            Mechanism Of Action

                                                                                                              R&D Progress

                                                                                                                Small Molecules to Antagonize GPR4 for Arthritis, Hyperalgesia and Oncology - Drug Profile

                                                                                                                  Product Description

                                                                                                                    Mechanism Of Action

                                                                                                                      R&D Progress

                                                                                                                        ZH-853 - Drug Profile

                                                                                                                          Product Description

                                                                                                                            Mechanism Of Action

                                                                                                                              R&D Progress

                                                                                                                                Hyperalgesia - Dormant Projects

                                                                                                                                  Appendix

                                                                                                                                    Methodology

                                                                                                                                      Coverage

                                                                                                                                        Secondary Research

                                                                                                                                          Primary Research

                                                                                                                                            Expert Panel Validation

                                                                                                                                              Contact Us

                                                                                                                                                Disclaimer

                                                                                                                                                Hyperalgesia - Pipeline Review, H2 2019

                                                                                                                                                Summary

                                                                                                                                                Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperalgesia - Pipeline Review, H2 2019, provides an overview of the Hyperalgesia (Central Nervous System) pipeline landscape.

                                                                                                                                                Hyperalgesia is an increase in pain response. Predisposing factors include long term opioid usage, inflammation, damage to nociceptors, damage to peripheral nerves and psychological disorders. Treatment includes antidepressants and Non-steroidal anti-inflammatory drugs.

                                                                                                                                                Report Highlights

                                                                                                                                                Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Hyperalgesia - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Hyperalgesia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                                                The Hyperalgesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Hyperalgesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 1 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.

                                                                                                                                                Hyperalgesia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                                                Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

                                                                                                                                                Scope

                                                                                                                                                - The pipeline guide provides a snapshot of the global therapeutic landscape of Hyperalgesia (Central Nervous System).
                                                                                                                                                - The pipeline guide reviews pipeline therapeutics for Hyperalgesia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                                                - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                                                - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                                                - The pipeline guide reviews key companies involved in Hyperalgesia (Central Nervous System) therapeutics and enlists all their major and minor projects.
                                                                                                                                                - The pipeline guide evaluates Hyperalgesia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                                                - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                                                - The pipeline guide reviews latest news related to pipeline therapeutics for Hyperalgesia (Central Nervous System)

                                                                                                                                                Reasons to buy

                                                                                                                                                - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                                                - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                                                - Find and recognize significant and varied types of therapeutics under development for Hyperalgesia (Central Nervous System).
                                                                                                                                                - Classify potential new clients or partners in the target demographic.
                                                                                                                                                - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                                                - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                                                - Formulate corrective measures for pipeline projects by understanding Hyperalgesia (Central Nervous System) pipeline depth and focus of Indication therapeutics.
                                                                                                                                                - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                                                - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


                                                                                                                                                Summary:
                                                                                                                                                Get latest Market Research Reports on Hyperalgesia. Industry analysis & Market Report on Hyperalgesia is a syndicated market report, published as Hyperalgesia - Pipeline Review, H2 2019. It is complete Research Study and Industry Analysis of Hyperalgesia market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                                                Last updated on

                                                                                                                                                REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                Purchase this Report

                                                                                                                                                $2,000.00
                                                                                                                                                $4,000.00
                                                                                                                                                $6,000.00
                                                                                                                                                1,488.97
                                                                                                                                                2,977.94
                                                                                                                                                4,466.91
                                                                                                                                                1,648.43
                                                                                                                                                3,296.85
                                                                                                                                                4,945.28
                                                                                                                                                208,188.00
                                                                                                                                                416,376.00
                                                                                                                                                624,564.00
                                                                                                                                                147,697.60
                                                                                                                                                295,395.20
                                                                                                                                                443,092.80
                                                                                                                                                Credit card Logo

                                                                                                                                                Related Reports


                                                                                                                                                Reason to Buy

                                                                                                                                                Request for Sample of this report